IOPtima is a rapidly growing company focused on developing minimally invasive and innovative surgical ophthalmic devices.

Its flagship product, the IOPtimate, is a surgical system for the treatment of glaucoma that utilizes CO2 laser technology to significantly reduce internal eye pressure without penetrating the eye.

The company also offers a line of patented eye drops to treat ocular surface diseases.IOPtima is a Kanghong Pharmaceutical company.